Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML
ClinicalTrials.gov study NCT05945849. IPD Sharing: NO. Countries: 1. Publications: 0.
RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS
ClinicalTrials.gov study NCT00819546. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
ClinicalTrials.gov study NCT07384715. IPD Sharing: NO. Countries: 0. Publications: 0.
To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS
ClinicalTrials.gov study NCT05740917. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Leptin: A Marker for AML Chemo-Sensitivity
ClinicalTrials.gov study NCT07163728. IPD Sharing: NO. Countries: 1. Publications: 0.
Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)
ClinicalTrials.gov study NCT04395092. IPD Sharing: NO. Countries: 1. Publications: 0.
Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01329471. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML
ClinicalTrials.gov study NCT00430443. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
ClinicalTrials.gov study NCT05224661. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDS
ClinicalTrials.gov study NCT04166929. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Beat AML Core Study
ClinicalTrials.gov study NCT02927106. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
ClinicalTrials.gov study NCT07270978. IPD Sharing: NO. Countries: 1. Publications: 0.
Drug-screening in AML at Relapse for Targeted Treatment
ClinicalTrials.gov study NCT05732688. IPD Sharing: YES. Countries: 1. Publications: 0.
Motixafortide for MRD Sensitization in AML
ClinicalTrials.gov study NCT07392970. IPD Sharing: YES. Countries: 1. Publications: 0.
Epidemiology of Infection in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06797648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
ClinicalTrials.gov study NCT03897127. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of the Predictive Marker FLT in Patients Suffering From AML
ClinicalTrials.gov study NCT01599429. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT06197672. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine
ClinicalTrials.gov study NCT00655395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients
ClinicalTrials.gov study NCT06162325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.